imiquimod has been researched along with Co-infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barroso Dos Reis, HL; Campos, LG; da Silva Campos, LC; Jacomele Caldas, JV; Miranda, AE; Pedras Almeida, SL; Salume Costa, FL; Tosato Boldrini, NA | 1 |
| Dressler, C; Nast, A; Werner, RN; Westfechtel, L | 1 |
| Chirachanakul, P; Jiamton, S; Leeyaphan, C; Omcharoen, V; Prasertworonun, N; Punyaratabandhu, P; Surawan, TM | 1 |
| Drutskaya, MS; Korneev, KV; Kuprash, DV; Nedospasov, SA; Sviriaeva, EN | 1 |
1 review(s) available for imiquimod and Co-infection
| Article | Year |
|---|---|
Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Coinfection; Female; Genital Diseases, Female; Genital Diseases, Male; HIV Seropositivity; Humans; Imiquimod; Immunocompetence; Male; Neoplasm Recurrence, Local; Papillomavirus Infections; Randomized Controlled Trials as Topic; Warts | 2017 |
3 other study(ies) available for imiquimod and Co-infection
| Article | Year |
|---|---|
Hypertrophic genital herpes in an HIV-infected female patient: Imiquimod as an alternative treatment.
Topics: Antiviral Agents; Coinfection; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Middle Aged; Ulcer; Vulva | 2020 |
Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study.
Topics: Acyclovir; Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ulcer | 2015 |
Modeling of viral-bacterial coinfections at the molecular level using agonists of innate immunity receptors.
Topics: Aminoquinolines; Animals; Bacterial Infections; Bone Marrow; Cells, Cultured; Coinfection; Cytokines; Disease Models, Animal; Imiquimod; Immunity, Innate; Interleukin-1beta; Interleukin-6; Ligands; Lipopolysaccharides; Macrophage Activation; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; RNA, Messenger; Toll-Like Receptor 4; Toll-Like Receptor 7; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Virus Diseases | 2016 |